IIRC, it wasn't that patients reported increased blodflow down there, but that a unusually large number of patients didn't return the drugs after the trial ende

IIRC, it wasn't that patients reported increased blodflow down there, but that a unusually large number of patients didn't return the drugs after the trial ended. So the researchers asked around, and learned that they trial patients didn't want to give up this "bonus".